Carpmaels escapes €1bn claim in BASF patent row

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Carpmaels escapes €1bn claim in BASF patent row

c0a6c8dd-7096-4a29-82d8-63ce4a28fe8bhigh-court-mw-600-comp.jpg

Shakespearean analogies fail to convince High Court that BASF’s €1bn claim has merit as company awarded only ‘nominal’ damages in Carpmaels patent row

Carpmaels & Ransford has escaped a major damages claim in the England and Wales High Court after German company BASF unsuccessfully claimed the firm’s negligence resulted in the company suffering €1.05bn ($1.2bn) in lost profits.

In a judgment yesterday, October 29, Mr Justice Adam Johnson ruled that BASF should be entitled to only “nominal damages” after Carpmaels missed a deadline for filing an appeal against a patent revocation.

Those damages will be decided at a later date. The final amount could range anywhere between just a few pounds and several hundred pounds.

Carpmaels had already admitted it was responsible for the loss of the appeal but contended that the appeal had little chance of success.

The numbers claimed in the trial, which began in April this year, were eye watering. BASF alleged that the total loss of profits it suffered from Carpmaels missing the deadline to appeal was €1.05 billion.

Although BASF argued these were its calculated losses, it invited the court to conclude the precise losses suffered.

The dispute centred on European patent 1,663,458 (‘458 patent) which, according to the claim, occupied “vital space” in relation to complying with diesel emission standards.

BASF contended that Carpmaels, which admitted negligence on its part, failed to file an appeal in time after the EPO revoked the ‘458 patent in 2012.

BASF said that had the appeal succeeded, the revocation would never have taken effect and the company would have had a valid patent until July 2024.

It added that it would have been able to seek damages from other competitors adjudged to have allegedly infringed the ‘458 patent, and could have cemented itself as a “market leader at a crucial time for NOx emissions products”.

However, Mr Justice Johnson was unconvinced.

“I am not persuaded that overall the claimants lost any real chance of achieving greater awards of business or negotiating more favourable licence terms,” he found.

The judgment came despite the best efforts of BASF’s counsel Roger Stewart QC, who during proceedings quoted Brutus in William Shakespeare’s Julius Caesar, exclaiming: “There is a tide in the affairs of men, which, taken at the flood, leads on to fortune.”

Johnson said: “According to Mr Stewart QC, the tide would have been in for the claimants. Because of Carpmaels’ negligence, they missed it.”

The judge agreed with Carpmaels’ defence, namely that any appeal against the patent’s validity was unlikely to succeed in the first place.

“The likelihood of BASF’s case succeeding on its appeal was less than 50/50,” Johnson found. 

“While accepting that there were arguments in both directions, including arguments in favour of validity which could be (and were) properly made, I am persuaded that there were fundamental difficulties with the ‘458 patent which, overall, would have made it less likely than not that any appeal would succeed.”

He added: “My overall assessment is that the claimants are entitled only to nominal damages resulting from Carpmaels’ admitted breach.”

Stewart QC and Pippa Manby of 4 New Square and Miles Copeland of Three New Square, instructed by Reed Smith, acted for BASF. John Wardell QC of Wilberforce Chambers, Henry Ward of 8 New Square and Nick Zweck of Hogarth Chambers, instructed by Clyde & Co, represented Carpmaels & Ransford.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article